News search

E.g., 09/06/2025
E.g., 09/06/2025
Cristina García Cáceres
team photo
About the CNIC
11 Jun 2024

iSuRe-HadCre promises to become an essential tool for biomedical research using mouse models to modify and understand gene function

 Dr. Fuster
About the CNIC
15 May 2024

Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total


María Linarejos Vera, Gema Mondéjar, Amaia Talavera, Patricia Sánchez, Álvaro Macías, Juan Manuel Ruiz, Francisco M. Cruz, Fernando Martínez de Benito, Juan Antonio Bernal y José Jalife
Research
11 Apr 2024

CNIC researchers, led by Dr. José Jalife, have made a key discovery about cardiac arrhythmias in Andersen-Tawil syndrome (ATS)

 Rodrigo Fernández Jiménez ha sido galardonado con el Premio Nacional de Investigación para Jóvenes ‘Gabriella Morreale’
About the CNIC
15 Mar 2024

The award honours the quality and relevance of his research work in preventive medicine and on current challenges in the field of cardiology


Ljubica Matic
Research
12 Mar 2024

Associate Professor in Molecular Medicine and Principal Researcher of the Vascular Surgery Division at Karolinska Institute

About the CNIC
9 Feb 2024

The National Center for Cardiovascular Research Carlos III (CNIC) is excited to announce the upcoming edition of the CNIC Conferences

Carlos Torroja, Jacob F. Bentzon, Paula Nogales, Laura Carramolino, Vanessa Cumbicus, Daniel Morales, Ana Dopazo, Verónica Labrador y Alberto Benguria
Research
1 Feb 2024

A study published in Nature Cardiovascular Research reveals smooth muscle-derived cells as a new target for reducing the size of atherosclerotic plaque. The results open up new avenues for the design of treatments to enhance the beneficial effect of cholesterol-lowering drugs


Catarina Tristão Pereira, Enrique Lara Pezzi, Raquel Toribio Fernández, Borja Ibáñez, Valentín Fuster, Sergio Callejas, Marta Cortés Canteli, Ana Dopazo, Pilar Martín, Inés García Lunar e Irene Fernández Nueda.
Research
23 Jan 2024

The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis